芪龙胶囊调控P2Y12/AC/cAMP通路改善多发脑梗死后微胶质功能并抑制血小板活化
本研究以7-8周龄雄性SD大鼠建立多发脑梗死模型,观察芪龙胶囊的神经行为学效应及对微胶质和血小板的影响。结果显示芪龙胶囊改善神经行为、握力和空间记忆,减轻脑组织与神经元损伤,抑制炎症、微胶质活化及血小板聚集,其机制可能与调控P2Y12/AC/cAMP信号通路有关。
要点
- 芪龙胶囊可改善多发脑梗死大鼠神经行为、握力与空间记忆。
- 芪龙胶囊抑制微胶质活化并降低TSPO表达,减轻炎症反应。
- 芪龙胶囊抑制血小板聚集,降低CD62p和CD61表达。
核心结论
- 芪龙胶囊可改善多发脑梗死大鼠的神经元坏死和多梗死性痴呆,并具有抗血小板聚集作用。
- 芪龙胶囊可能通过调控P2Y12/AC/cAMP信号通路治疗多梗死性痴呆。
研究设计与样本
- 采用7-8周龄、体重210-230 g的雄性SD大鼠建立多发脑梗死模型,以芪龙胶囊为干预。
- 通过体重、神经功能评分、前肢抓力和水迷宫评估神经行为,采用HE染色、银染色、透射电镜和PET/CT观察神经元与微胶质。
主要发现
- 芪龙胶囊改善多发脑梗死后的神经行为学指标、前肢握力和空间记忆,并改善脑组织和神经元损伤。
- 芪龙胶囊有效抑制多发脑梗死后的炎症反应,减少微胶质活化并降低TSPO表达。
- 芪龙胶囊改善血小板聚集率,降低CD62p和CD61表达,具有明显抗血小板聚集作用。
- 芪龙胶囊影响cAMP和cGMP含量,降低微胶质中P2Y12表达,调控P2Y12/AC/cAMP信号通路。
临床怎么用
- 芪龙胶囊源自补阳还五汤,适用于缺血性卒中后遗症如多梗死性痴呆,其神经保护与抗血小板机制涉及P2Y12/AC/cAMP通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Multiple cerebral infarctions (MCIs) represent a common type of ischaemic stroke that affects or even endangers a patient's life. Qilong capsule (QLC), a Chinese patent medicine made from Buyang Huanwu Decoction (BYHWD) is suitable for treating the sequelae of ischaemic stroke, such as multi-infarct dementia (MID). However, its biological mechanism has not been fully explored. AMI OF THE STUDY: The aim of this study was to explore the mechanism of QLC in treating MCI and its sequelae. METHODS: Male SD rats aged 7-8 weeks and weighing 210-230 g were used as an MCI model, and QLC was used as interventions. The neurobehavioural effects of QLC on MCI model rats were evaluated by observing body weight, neurological function score, and forelimb grip and water maze test results. The effects of QLC on neurons and microglia were observed via haematoxylin‒eosin (HE) staining, silver staining, transmission electron microscopy and positron emission tomography/computed tomography (PET/CT). The effects of QLC on platelets were observed via the platelet aggregation rate and flow cytometry (FCM). Finally, the mechanism of QLC was verified via ELISA, immunofluorescence staining and Western blotting. RESULTS: These experiments showed that QLC improves neurobehavioural measures, forelimb grip strength, and spatial memory after MCI by ameliorating brain tissue and neuronal damage. QLC also effectively inhibited the inflammatory response after MCI. We also found that QLC can decrease microglia activation and reduce the expression of translocator protein 18 kDa (TSPO). QLC can improve platelet aggregation and reduce the expression of CD62p and CD61, indicating that QLC has a significant anti-platelet aggregation effect. At the molecular level, we found that QLC affects the content of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), reduces the expression of recombinant purinergic receptor P2Y, G protein coupled 12 (P2Y12) in microglia, and regulates the P2Y12/adenylate cyclase (AC)/cAMP signalling pathway. CONCLUSIONS: QLC can ameliorate neuronal necrosis and MID induced by MCI and has an antiplatelet aggregation effect in rats. QLC may treat MID by regulating P2Y12/AC/cAMP.
引用
- Zhan M, Zheng X, Gao J, et al. Qilong capsule regulates microglial function and inhibits platelet activation after multiple cerebral infarctions by regulating the P2Y12/AC/cAMP signalling pathway. J Ethnopharmacol. 2025. PMID: 40054638. doi:10.1016/j.jep.2025.119586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。